CoChat

The DOI matches its Crossref record; 51 of the 54 references it cites were found in a registry or an index; 10 of the 28 sources its claims cite were checked for support.

Acceptance and Commitment Therapy for Muscle Disease (ACTMus): protocol for a two-arm randomised controlled trial of a brief guided self-help ACT programme for improving quality of life in people with muscle diseases

Open access

Abstract

Introduction In adults, muscle disease (MD) is often a chronic long-term condition with no definitive cure. It causes wasting and weakness of the muscles resulting in a progressive decline in mobility, alongside other symptoms, and is typically associated with reduced quality of life (QoL). Previous research suggests that a psychological intervention, and in particular Acceptance and Commitment Therapy (ACT), may help improve QoL in MD. ACT is a newer type of cognitive behavioural treatment that aims to improve QoL by virtue of improvement in a process called psychological flexibility. The primary aim of this randomised controlled trial (RCT) is to evaluate the efficacy of a guided self-help ACT programme for improving QoL in people with MD. Main secondary outcomes are mood, symptom impact, work and social adjustment and function at 9-week follow-up. Methods and analysis Acceptance and Commitment Therapy for Muscle Disease is an assessor-blind, multicentre, two-armed, parallel-group RCT to assess the efficacy of ACT plus standard medical care (SMC) compared with SMC alone. Individuals with a diagnosis of one of four specific MDs, with a duration of at least 6 months and with mild to moderate anxiety or depression (Hospital Anxiety and Depression Scale score ≥8) will be recruited from UK-based MD clinics and MD patient support organisations. Participants will be randomised to either ACT plus SMC or SMC alone by an independent randomisation service. Participants will be followed up at 3, 6 and 9 weeks. Analysis will be intention to treat, conducted by the trial statistician who will be blinded to treatment allocation. Ethics and dissemination The study has received full ethical approval. Study results will be disseminated via peer-reviewed publications, conference presentations and journal articles. Data obtained from the trial will enable clinicians and health service providers to make informed decisions regarding the efficacy of ACT for improving QoL for patients with MD. Trial registration number NCT02810028. Protocol version V.11 (4 April 2017). © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY. Published by BMJ.

Overview

CoChat Summary

## TL;DR

This is a protocol for the ACTMus trial, a two-arm assessor-blind RCT testing whether a brief remotely delivered guided self-help Acceptance and Commitment Therapy (ACT) programme plus standard medical care improves quality of life in adults with muscle diseases. The primary endpoint is 9 weeks, with 154 participants planned and secondary outcomes including mood, symptom impact, work/social adjustment, and function.

## Key findings

  • Not stated in the paper.
  • The trial is powered to recruit 154 patients total, 77 per arm, to detect a standardised mean difference of 0.5 with 5% significance and 80% power, assuming 20% attrition.
  • The intervention consists of 4 modules plus 5 telephone support sessions; the first three modules are expected to take 1 hour 30 min each and the final module 45 min.
  • The paper states this is the first randomised controlled trial to test ACT for muscle diseases against standard medical care, and “the largest trial of a psychological intervention for MD that primarily targets quality of life.”

## Methods

  • Design: Assessor-blind, multicentre, two-armed, parallel-group RCT comparing ACT plus standard medical care (SMC) vs SMC alone, with follow-up at 3, 6, and 9 weeks.
  • Sample/data: Planned recruitment of 154 adults with one of four muscle diseases (LGMD, BMD, FSHD, IBM), duration >6 months, and HADS ≥8 for anxiety or depression; recruitment from UK NHS MD clinics, MD-UK, and disease registries.
  • Analysis: Intention-to-treat; primary outcome is change in INQoL life area domains / QoL score to 9 weeks, analyzed with linear mixed-effects models including treatment arm, time, arm-by-time interaction, baseline QoL, and recruiting centre.

## Limitations

  • The paper explicitly states that only a short follow-up period is included, so it will not be able to investigate longer-term treatment effects.
  • The paper states an intrinsic limitation is the lack of comparable therapist time and attention in the SMC-alone group.
  • Evident from the protocol (not stated as a limitation by the authors): this paper reports a trial protocol, so it contains no results on efficacy or outcomes.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/bmjopen-2018-022083

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Consort diagram for ACTMus. ACT, Acceptance and Commitment Therapy; ACTMus, Acceptance and Commitment Therapy for Muscle Disease; MD, muscle disease; SMC, standard medical care.
Figure 1 Consort diagram for ACTMus. ACT, Acceptance and Commitment Therapy; ACTMus, Acceptance and Commitment Therapy for Muscle Disease; MD, muscle disease; SMC, standard medical care.CC BY · PubMed Central

Verification

Claims the paper makes

10 Valid · 0 Not valid · 9 Not checked · 20 Own results and interpretations

11 more claims · 3 with their cited sources checked

Create a free account to see all 39 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 12
  • Probably not a substantial claim. 18

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 51 references

Research works printed but not linked: 1

  1. 10.1097/00005650-200305000-00007 · DOI

Cited by

See all 15

Metadata

Authors
Rose, M. R., Norton, S., Vari, C., Edwards, V., McCracken, L., Graham, C. D., Radunovic, A., & Chalder, T.
Affiliations
  • King's College Hospital (GB)
  • King's College London (GB)
  • University of Leeds (GB)
  • Royal London Hospital, Barts and the London MND Centre, London, UK
Corresponding author
Rose, Michael R
Venue
BMJ Open
Publisher
BMJ
Published
2018-10
Volume
8
Issue
10
Pages
e022083
ISSN
2044-6055 (ISSN-L)
OpenAlex
W2884540777
Cited by
15
References
54
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 2 · 2019: 2
FWCI
1.17
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • BMJ Open (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (acceptedVersion, other-oa)
  • Research Portal (Queen's University Belfast) (acceptedVersion, cc-by)
  • Research Portal (King's College London) (submittedVersion, other-oa)
Funders
  • Muscular Dystrophy UK
  • National Institute for Health Research
Topics
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
acceptance and commitment therapy, myopathy, quality of life, guided self-help, psychological flexibility, anxiety, depression, work and social adjustment, psychological intervention
MeSH terms
United Kingdom, Humans, Muscular Diseases, Quality of Life, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Patient Satisfaction, Outcome Assessment, Health Care, Chronic Pain, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acceptance and Commitment Therapy for Muscle Disease (ACTMus): protocol for a two-arm randomised controlled trial of a brief guided self-help ACT programme for improving quality of life in people with muscle diseases. https://app.cochat.ai/papers/10.1136/bmjopen-2018-022083
The paper
Rose, M. R., Norton, S., Vari, C., Edwards, V., McCracken, L., Graham, C. D., Radunovic, A., & Chalder, T. (2018). Acceptance and Commitment Therapy for Muscle Disease (ACTMus): protocol for a two-arm randomised controlled trial of a brief guided self-help ACT programme for improving quality of life in people with muscle diseases. BMJ Open. https://doi.org/10.1136/bmjopen-2018-022083

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.